A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer

Song, T; Wu, Q; Cui, YL; Li, HK; Zhang, W; Fang, F; Xiong, QQ

CANCER RESEARCH, 2023; 83 (7):